Analyst Ratings for Viridian Therapeutic (VRDN)
VRDN Rating Summary
VRDN Price Target Summary
- Highest: $61.00 (BTIG)
- Lowest: $29.00 (Wells Fargo)
- Average: $43.08
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$43.08 (+52%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$43.08 (+52%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/7/2026 | UBS | Michael Yee | New Coverage | Buy (N/A) |
50.00 (N/A) |
30.20 (28.34) |
-6.16% | Details |
| 12/3/2025 | William Blair | Lachlan Hanbury-Brown | New Coverage | Outperform (N/A) |
N/A (N/A) |
30.43 (28.34) |
-6.87% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
